Repertoire Immune Medicines Doses First Patient in Groundbreaking Cancer Trial with Novel T Cell Therapy#United_States#Cambridge#T_Cell_Therapy#Repertoire_Immune#RPTR-1-201
Repertoire Immune Medicines Doses First Patient in Groundbreaking Cancer Trial with Novel T Cell Therapy
Repertoire Immune Medicines has announced the dosing of the first participant in a Phase 1/2 trial of RPTR-1-201, its innovative immune therapy aimed at treating advanced solid tumors.
third-news.com
April 23, 2026 at 12:36 PM
Repertoire Immune Medicines Doses First Patient in Groundbreaking Cancer Trial with Novel T Cell Therapy#United_States#Cambridge#T_Cell_Therapy#Repertoire_Immune#RPTR-1-201
Groundbreaking Research on T Cell Therapies for HPV-Related Cancers Shows Promise in Long-Term Remissions#United_States#HPV_cancer#T_Cell_Therapy#New_Brunswick,_New_Jersey#Rutgers_Institute
Groundbreaking Research on T Cell Therapies for HPV-Related Cancers Shows Promise in Long-Term Remissions
Recent findings from Rutgers Cancer Institute reveal that innovative T cell therapies for HPV-associated cancers can lead to significant and lasting remissions, providing hope to patients with limited treatment options.
third-news.com
November 7, 2025 at 6:43 PM
Groundbreaking Research on T Cell Therapies for HPV-Related Cancers Shows Promise in Long-Term Remissions#United_States#HPV_cancer#T_Cell_Therapy#New_Brunswick,_New_Jersey#Rutgers_Institute
Myrio Therapeutics Collaborates with Top Institutions to Innovate T Cell Immunotherapy for Solid Tumors#USA#Philadelphia#Cancer_Research#T_Cell_Therapy#Myrio_Therapeutics
Myrio Therapeutics Collaborates with Top Institutions to Innovate T Cell Immunotherapy for Solid Tumors
Myrio Therapeutics has partnered with top research institutions to fast-track the development of advanced T cell immunotherapies targeting solid tumors, showcasing promising advances in cancer treatment.
third-news.com
October 28, 2025 at 11:37 AM
Myrio Therapeutics Collaborates with Top Institutions to Innovate T Cell Immunotherapy for Solid Tumors#USA#Philadelphia#Cancer_Research#T_Cell_Therapy#Myrio_Therapeutics
Akadeum Life Sciences and BioIVT Join Forces for Enhanced Cell Therapy Solutions#United_States#Ann_Arbor#T_Cell_Therapy#Akadeum_Life_Sciences#BioIVT
Akadeum Life Sciences and BioIVT Join Forces for Enhanced Cell Therapy Solutions
Akadeum Life Sciences partners with BioIVT to enhance the quality of T cells for cell therapy development. This collaboration aims to improve the efficiency and outcomes of therapies.
third-news.com
October 14, 2025 at 12:47 PM
Akadeum Life Sciences and BioIVT Join Forces for Enhanced Cell Therapy Solutions#United_States#Ann_Arbor#T_Cell_Therapy#Akadeum_Life_Sciences#BioIVT
Transforming T Cell Therapy Manufacturing: A Revolutionary Partnership between Made Scientific and Syenex#USA#Princeton#Syenex#T_Cell_Therapy#Made_Scientific
Transforming T Cell Therapy Manufacturing: A Revolutionary Partnership between Made Scientific and Syenex
Made Scientific and Syenex have partnered to enhance T cell therapy manufacturing efficiency and scalability through innovative technology, addressing industry challenges.
third-news.com
September 30, 2025 at 5:55 PM
Transforming T Cell Therapy Manufacturing: A Revolutionary Partnership between Made Scientific and Syenex#USA#Princeton#Syenex#T_Cell_Therapy#Made_Scientific
Neowise Biotechnology and BeOne Medicines Collaborate to Develop Innovative Cell Therapies#China#Suzhou#Neowise_Biotechnology#BeOne_Medicines#TCR-T_cell_therapy
Neowise Biotechnology and BeOne Medicines Collaborate to Develop Innovative Cell Therapies
Neowise Biotechnology and BeOne Medicines have entered a licensing agreement to enhance the development of cutting-edge cell therapies for cancer treatment.
third-news.com
June 9, 2025 at 12:06 PM
Neowise Biotechnology and BeOne Medicines Collaborate to Develop Innovative Cell Therapies#China#Suzhou#Neowise_Biotechnology#BeOne_Medicines#TCR-T_cell_therapy
Repertoire Immune Medicines and Genentech Form Partnership to Innovate Autoimmune Treatments#USA#Cambridge#T_Cell_Therapy#Repertoire_Immune#Genentech
Repertoire Immune Medicines and Genentech Form Partnership to Innovate Autoimmune Treatments
Repertoire Immune Medicines teams up with Genentech to develop innovative T cell-targeted therapies for autoimmune diseases, utilizing their advanced DECODE™ platform.
third-news.com
April 23, 2025 at 11:14 AM
Repertoire Immune Medicines and Genentech Form Partnership to Innovate Autoimmune Treatments#USA#Cambridge#T_Cell_Therapy#Repertoire_Immune#Genentech
Dr. Crystal Mackall Recognized for Transformative Contributions to T Cell Therapies#United_States#Boston#T_Cell_Therapy#Crystal_Mackall#IO360_Award
Dr. Crystal Mackall Recognized for Transformative Contributions to T Cell Therapies
Dr. Crystal Mackall has been awarded the IO360º Lifetime Achievement Award for her groundbreaking achievements in T cell therapies, notably revolutionizing cancer treatment strategies.
third-news.com
April 8, 2025 at 11:18 AM
Dr. Crystal Mackall Recognized for Transformative Contributions to T Cell Therapies#United_States#Boston#T_Cell_Therapy#Crystal_Mackall#IO360_Award
TC BioPharm Unveils Strategic Outsourcing To Streamline Operations and Boost Efficiency#United_Kingdom#Edinburgh#TC_BioPharm#T_Cell_Therapy#Bryan_Kobel
TC BioPharm Unveils Strategic Outsourcing To Streamline Operations and Boost Efficiency
In a significant strategic move, TC BioPharm announces outsourcing initiatives to reduce operational costs, transitioning to a decentralized model to enhance efficiency.
third-news.com
March 18, 2025 at 12:05 PM
TC BioPharm Unveils Strategic Outsourcing To Streamline Operations and Boost Efficiency#United_Kingdom#Edinburgh#TC_BioPharm#T_Cell_Therapy#Bryan_Kobel
Swarm Oncology Partners with Cellex to Revolutionize T Cell Therapies for Cancer Treatment#USA#London#T_Cell_Therapy#Swarm_Oncology#Cellex
Swarm Oncology Partners with Cellex to Revolutionize T Cell Therapies for Cancer Treatment
Swarm Oncology and Cellex enter a strategic partnership aiming to accelerate the development of groundbreaking T cell cancer therapies.
third-news.com
February 24, 2025 at 1:12 PM
Swarm Oncology Partners with Cellex to Revolutionize T Cell Therapies for Cancer Treatment#USA#London#T_Cell_Therapy#Swarm_Oncology#Cellex
Triumvira Immunologics Unveils Innovative Data on T Cell Therapies at ASCO 2025#USA#San_Francisco#Cancer_Treatment#T_Cell_Therapy#Triumvira
Triumvira Immunologics Unveils Innovative Data on T Cell Therapies at ASCO 2025
Triumvira Immunologics showcased promising clinical data on their targeted T cell therapeutics at the ASCO 2025 Gastrointestinal Cancers Symposium.
third-news.com
January 27, 2025 at 1:21 PM
Triumvira Immunologics Unveils Innovative Data on T Cell Therapies at ASCO 2025#USA#San_Francisco#Cancer_Treatment#T_Cell_Therapy#Triumvira
TC BioPharm Announces Participation in Sequire Investor Summit 2025#USA#San_Juan#TC_BioPharm#T_Cell_Therapy#Investor_Summit
TC BioPharm Announces Participation in Sequire Investor Summit 2025
TC BioPharm will showcase its innovative T cell therapies at the Sequire Investor Summit in Puerto Rico, highlighting its clinical advancements.
third-news.com
January 13, 2025 at 1:57 PM
TC BioPharm Announces Participation in Sequire Investor Summit 2025#USA#San_Juan#TC_BioPharm#T_Cell_Therapy#Investor_Summit